Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-286466
Filing Date
2025-11-18
Accepted
2025-11-18 17:27:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d846460d424b5.htm 424B5 488139
2 GRAPHIC g846460g33y04.jpg GRAPHIC 34734
3 GRAPHIC g846460g57c33.jpg GRAPHIC 79977
4 GRAPHIC g846460g81e43.jpg GRAPHIC 70238
  Complete submission text file 0001193125-25-286466.txt   744349
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284146 | Film No.: 251496020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)